nedaplatin has been researched along with Cancer of Cervix in 76 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.32) | 18.7374 |
| 1990's | 11 (14.47) | 18.2507 |
| 2000's | 24 (31.58) | 29.6817 |
| 2010's | 36 (47.37) | 24.3611 |
| 2020's | 4 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Jiang, Y; Song, B | 1 |
| Fan, S; Feng, Y; Hou, T; Liu, X; Shan, M; Wang, J; Zhang, Y; Zou, W | 1 |
| Bai, Z; Cai, Q; Cao, X; Liu, J; Ouyang, Y; Su, J; Wang, Y; Xu, Q | 1 |
| Liang, MR; Liu, H; Wang, YN; Zeng, SY; Zhong, ML | 1 |
| Abiko, K; Baba, T; Hamanishi, J; Horie, A; Mandai, M; Matsuoka, H; Murakami, R; Yamaguchi, K | 1 |
| Haraga, J; Ida, N; Kiyotoki, T; Kusumoto, T; Masuyama, H; Nakamura, K; Nishida, T; Omichi, C; Saijo, M | 1 |
| Hayakawa, K; Inoue, Y; Matsuo, K; Niibe, Y; Onda, T | 1 |
| Fu, Z; Li, P; Long, M; Nie, Z; Zhang, G; Zhang, R | 1 |
| Miura, Y; Shoji, T; Sugiyama, T; Takatori, E; Takeuchi, S; Yoshizaki, A | 1 |
| Abou Taleb, H; Baba, T; Hamanishi, J; Kido, A; Konishi, I; Matsumura, N; Togashi, K; Yamaguchi, K; Yamanoi, K; Yoshioka, Y | 1 |
| Gao, YN; Li, CL; Li, DM; Li, XF; Li, YH; Su, X; Xu, G; Yue, HZ | 1 |
| An, J; Huang, M; Li, N; Wu, L; Yuan, G | 1 |
| Fuwa, N; Hirata, K; Ito, J; Kodaira, T; Nakanishi, T; Ohshima, Y; Tachibana, H; Tomita, N | 1 |
| Fujiwara, M; Hayashi, K; Isohashi, F; Kimura, T; Mabuchi, S; Ogawa, K; Seo, Y; Sumida, I; Suzuki, O; Yoshioka, Y | 1 |
| Jiang, JY; Li, WJ; Wang, XL | 1 |
| Guo, J; Han, J; Ji, Y; Pan, P; Yu, C; Zhou, X; Zhu, W | 1 |
| Abe, M; Hirashima, Y; Kuji, S; Takahashi, N; Takekuma, M; Tanaka, A | 1 |
| Isohashi, F; Kimura, T; Kinose, Y; Kozasa, K; Mabuchi, S; Ogawa, K; Otani, Y; Seo, Y; Sumida, I; Suzuki, O; Tamari, K; Unno, H; Yamashita, M; Yoshioka, Y | 1 |
| Honda, T; Kagabu, M; Miura, F; Mizunuma, H; Murakami, K; Nagase, S; Ohta, T; Omi, H; Sato, N; Shimizu, D; Shoji, T; Soeda, S; Sugiyama, T; Takano, T; Tase, T; Tokunaga, H; Watanabe, T; Yaegashi, N; Yamada, H; Yokoyama, Y | 1 |
| Abiko, K; Abou-Taleb, HA; Baba, T; Hamanishi, J; Horikawa, N; Kitamura, S; Konishi, I; Koshiyama, M; Matsumura, N; Murakami, R; Taha, AA; Yamaguchi, K; Yamanoi, K | 1 |
| Cui, J; Hu, B; Qu, H; Song, Y; Tao, J; Wang, L; Zhang, Y | 1 |
| Fuwa, N; Inokuchi, H; Kodaira, T; Nakahara, R; Nakamura, T; Nakanishi, T; Tachibana, H; Tomita, N | 1 |
| Hayakawa, K; Imai, M; Jobo, T; Matsunaga, K; Matsuo, K; Niibe, Y; Tsunoda, S; Unno, N | 1 |
| Hasegawa, K; Kokawa, K; Konishi, I; Nishida, M; Nishimura, R; Noguchi, H; Saji, F; Takizawa, K; Umesaki, N; Yamamoto, K | 1 |
| Gomi, H; Ishizuka, B; Kiguchi, K; Kobayashi, Y; Kondo, H; Ohara, T; Okuda, Y; Okuma, Y; Suzuki, N; Wada, Y | 1 |
| Enomoto, T; Inoue, T; Isohashi, F; Kimura, T; Mabuchi, S; Morishige, K; Takeda, T; Yamamoto, T; Yoshino, K; Yoshioka, Y | 1 |
| Enomoto, T; Inoue, T; Isohashi, F; Kimura, T; Kuragaki, C; Mabuchi, S; Morishige, K; Nakajima, R; Takeda, T; Temma, K; Ugaki, H; Yada-Hashimoto, N; Yamamoto, T; Yoshino, K; Yoshioka, Y | 1 |
| Liu, SP; Wang, XE; Zhang, MQ | 1 |
| Akiyama, F; Kawamata, Y; Matsumura, M; Omatsu, K; Ota, T; Sakamoto, K; Takeshima, N; Takizawa, K; Tanaka, H; Umayahara, K | 1 |
| Enomoto, T; Isohashi, F; Kamiura, S; Kimura, T; Mabuchi, S; Maruoka, S; Morishige, K; Ohta, Y; Okazawa, M; Yoshioka, Y | 1 |
| Hamada, Y; Hayakawa, K; Kotani, A; Kusu, F; Naitoh, H; Niibe, Y; Takayanagi, R; Tsunoda, S; Unno, N; Yago, K; Yamada, Y | 1 |
| Chen, X; Li, H; Li, K; Li, X; Liu, Y; Lou, G; Yin, M; Zhang, H | 1 |
| Fujiwara, H; Itamochi, H; Kigawa, J; Machida, S; Oishi, T; Sato, S; Shimada, M; Suzuki, M; Takei, Y | 1 |
| Achiwa, Y; Hasegawa, K; Kato, R; Oe, S; Okamoto, H; Torii, Y; Udagawa, Y | 1 |
| Li, T; Yu, CH; Zhu, WG | 1 |
| Ke, QH; Liu, Z; Su, XY; Yang, JY; Zhang, WT; Zhou, SQ | 1 |
| Hasegawa, K; Kato, R; Kawamura, K; Kobayashi, Y; Okamoto, H; Sekiya, T; Udagawa, Y | 1 |
| Arakawa, A; Furukawa, N; Hirashima, Y; Itani, Y; Ito, K; Murakoshi, H; Tabata, T; Takekuma, M; Takeuchi, S; Tsubamoto, H | 1 |
| Hiura, M; Kiguchi, K; Kita, T; Kokawa, K; Kubushiro, K; Mizutani, K; Nishimura, R; Sugiyama, T; Takizawa, K; Yaegashi, N; Yamaguchi, S; Yamamoto, K | 1 |
| Hirota, S; Inoue, K; Ito, Y; Kanazawa, R; Komori, S; Maeda, H; Tsubamoto, H | 1 |
| Isohashi, F; Kimura, T; Koizumi, M; Konishi, K; Mabuchi, S; Maruoka, S; Ogata, T; Ogawa, K; Takahashi, Y; Yoshioka, Y | 1 |
| Kiguchi, K; Kobayashi, Y; Kondo, H; Ohara, T; Suzuki, N; Tozawa, A; Yahagi, N; Yoshida, A; Yoshioka, N | 1 |
| Cheng, X; Qian, J; Shi, TY; Tu, XY; Wei, Q; Wu, XH; Yang, G; Yang, JM; Zhou, XY | 1 |
| Chen, XJ; Cheng, X; He, J; Li, QX; Shao, ZM; Shi, TY; Sun, MH; Wang, MY; Wei, Q; Wu, X; Yu, KD; Zhou, XY; Zhu, ML | 1 |
| Isohashi, F; Kamiura, S; Kimura, T; Mabuchi, S; Ogawa, K; Ohta, Y; Okazawa, M; Sasano, T; Suzuki, O; Yoshioka, Y | 1 |
| Furutani, K; Fuwa, N; Ito, Y; Kamata, M; Kodaira, T; Matsumoto, A; Tachibana, H | 1 |
| Aso, T; Ichimura, M; Ohara, M; Otsuka, I; Shimabukuro, K; Somekawa, Y; Terauchi, T; Tsugata, M; Umeki, H; Wakana, K; Yamaguchi, Y | 1 |
| Chishima, F; Himi, K; Hiraiwa, Y; Idei, T; Kawamori, J; Nagaishi, M; Nakajima, Y; Ohtani, K; Sakamoto, H; Takami, N; Tanaka, Y; Yamamoto, T | 1 |
| Fujiwara, H; Kikuchi, Y; Kita, T; Komiyama, S; Konno, R; Machida, S; Mikami, M; Ohwada, M; Suzuki, M; Takano, M | 1 |
| Hashiguchi, Y; Kawamura, N; Miyama, M; Nakata, S; Negoro, S; Nishimura, S; Tsuda, H | 1 |
| Terauchi, F | 1 |
| Kinoshita, K; Tanaka, M; Yoshida, M | 1 |
| Ariyosh, Y; Fukuoka, M; Hasegawa, K; Hatae, M; Imajo, Y; Kamiura, S; Kodama, S; Kono, I; Kuzuya, K; Nakayama, H; Nishimura, R; Noda, K; Saji, F; Takahashi, T; Watanabe, Y | 1 |
| Ikeda, M; Ishigaki, T; Ishihara, S; Itoh, Y; Kawase, S; Okuda, T; Yanagawa, S | 1 |
| Ito, K; Nagase, S; Nemoto, K; Niikura, H; Ogawa, Y; Takano, T; Yaegashi, N; Yoshinaga, K | 1 |
| Arai, M; Arai, T; Hamada, Y; Hayakawa, K; Imai, M; Jobo, T; Kanai, T; Kawaguchi, M; Niibe, Y; Tsunoda, S; Unno, N; Yago, K | 1 |
| Jobo, T | 1 |
| Tanaka, T; Umesaki, N; Yukawa, K | 1 |
| Anzai, N; Hiruma, R; Kamide, T; Kamiya, N; Kotake, Y; Matsumoto, R; Sasaki, H; Shinozaki, H; Tada, A; Wachi, T | 1 |
| Kurachi, H; Mizunuma, H; Nakahara, K; Okamura, K; Sato, A; Sato, H; Shoji, T; Sugiyama, T; Takano, T; Tanaka, T; Tase, T; Yaegashi, N; Yamada, H; Yokoyama, Y | 1 |
| Hirabayashi, K; Okada, E | 1 |
| Hatae, M; Hirabayashi, K; Kanazawa, K; Noda, K; Ozaki, M; Terashima, Y; Yakushiji, M | 1 |
| Adachi, S; Koyama, K; Ogasawara, T; Takayasu, Y; Takemura, T; Yamasaki, N | 1 |
| Alberts, DS; Burger, RA; Fanta, PT; Hallum, AV; Hatch, KD; Monk, BJ; Salmon, SE | 1 |
| Adachi, S; Beppu, K; Chin, R; Hori, K; Itani, Y; Ito, K; Kawai, S; Koyama, M; Saito, K; Shintani, M | 1 |
| Kubo, T; Nishida, M; Nishide, K; Satoh, Y; Tsunoda, H | 1 |
| Adachi, S; Inoue, J; Koyama, K; Nakao, N; Ogasawara, T; Takayasu, Y; Takemura, T; Tsuji, Y; Wakimoto, E | 1 |
| Hashimoto, I; Hongo, A; Kodama, J; Kudo, T; Miyagi, Y; Mizutani, Y; Seki, N; Yoshinouchi, M | 1 |
| Hashimoto, N; Kamiura, S; Kobayashi, K; Ohira, H; Saji, F; Samejima, Y; Sawai, K; Seino, H | 1 |
| Adachi, S; Hori, Y; Koyama, K; Ogasawara, T; Oku, H; Takemura, T; Tsubamoto, H; Tsuji, Y | 1 |
| Karato, A; Miya, T; Saijo, N; Sasaki, Y | 1 |
| Akamatsu, Y; Hirabayashi, K; Nakanishi, Y; Nakazuma, Y; Ohta, M; Okada, E; Sezaki, H | 1 |
| Arai, M; Kato, T; Nishimura, H; Noda, K; Ota, M; Suzuki, M; Takamizawa, H; Takeuchi, S; Terashima, Y; Yakushiji, M | 1 |
| Hata, T; Ikeda, M; Kuramoto, H; Nishimura, H; Noda, K; Sasaki, H; Takahashi, T; Tanaka, K; Terashima, Y; Yakushiji, M | 1 |
| Hirabayashi, K; Oguma, T; Okada, E; Shimamura, K | 1 |
| Nishimura, H; Yakushiji, M | 1 |
2 review(s) available for nedaplatin and Cancer of Cervix
| Article | Year |
|---|---|
[Neoadjuvant intraarterial chemotherapy with nedaplatin, peplomycin and mitomycin C for advanced cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Middle Aged; Mitomycin; Neoadjuvant Therapy; Organoplatinum Compounds; Peplomycin; Prognosis; Survival Rate; Uterine Cervical Neoplasms | 2003 |
[Irinotecan hydrochloride (CPT-11) for advanced cervical cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Irinotecan; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Topoisomerase I Inhibitors; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
30 trial(s) available for nedaplatin and Cancer of Cervix
| Article | Year |
|---|---|
Multicentre, randomised controlled trial of adjuvant chemotherapy in cervical cancer with residual human papilloma virus DNA following primary radiotherapy or chemoradiotherapy: a study protocol.
Topics: Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Disease-Free Survival; DNA, Viral; Docetaxel; Female; Humans; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Papillomaviridae; Radiotherapy; Randomized Controlled Trials as Topic; Uterine Cervical Neoplasms | 2019 |
Phase II Study of Concurrent Chemoradiotheapy Using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma (KGROG0501): Final Results.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Treatment Outcome; Uterine Cervical Neoplasms | 2017 |
A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix.
Topics: Adult; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease Progression; Drug Administration Schedule; Female; Humans; Middle Aged; Organoplatinum Compounds; Treatment Outcome; Uterine Cervical Neoplasms | 2014 |
A comparative study of intensity-modulated radiotherapy and standard radiation field with concurrent chemotherapy for local advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Enteritis; Female; Humans; Middle Aged; Organoplatinum Compounds; Radiation Injuries; Radiotherapy, Intensity-Modulated; Uterine Cervical Neoplasms; Young Adult | 2015 |
Prospective study of alternating chemoradiotherapy consisting of extended-field dynamic conformational radiotherapy and systemic chemotherapy using 5-FU and nedaplatin for patients in high-risk group with cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Humans; Middle Aged; Organoplatinum Compounds; Prospective Studies; Radiotherapy, Conformal; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Humans; Japan; Middle Aged; Organoplatinum Compounds; Radiotherapy, High-Energy; Uterine Cervical Neoplasms | 2008 |
Phase I study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese gynecologic oncology group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Uterine Cervical Neoplasms | 2009 |
Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Paclitaxel; Radiotherapy; Remission Induction; Uterine Cervical Neoplasms | 2010 |
Evaluation of a formula for individual dosage of nedaplatin based on renal function.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Blood Platelets; Female; Humans; Kidney; Kidney Function Tests; Metabolic Clearance Rate; Middle Aged; Models, Theoretical; Organoplatinum Compounds; Ovarian Neoplasms; Platelet Count; Precision Medicine; Predictive Value of Tests; Uterine Cervical Neoplasms | 2012 |
[Analysis of the initial efficacy of nedaplatin combined with megestrol in concurrent chemoradiotherapy for advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Diarrhea; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Leukopenia; Megestrol; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Particle Accelerators; Radiotherapy, High-Energy; Remission Induction; Survival Rate; Thrombocytopenia; Uterine Cervical Neoplasms | 2011 |
Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Paclitaxel; Uterine Cervical Neoplasms | 2012 |
Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Humans; Hysterectomy; Irinotecan; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Uterine Cervical Neoplasms; Young Adult | 2012 |
Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP): adverse effects and eecommended dose of NDP administered after 5-FU.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Remission Induction; Uterine Cervical Neoplasms | 2002 |
[Concurrent weekly nedaplatin-based radiotherapy for high risk, recurrent and advanced cervical cancer].
Topics: Aged; Antineoplastic Agents; Brachytherapy; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Middle Aged; Organoplatinum Compounds; Pilot Projects; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2003 |
Phase I study of combination chemotherapy using irinotecan hydrochloride and nedaplatin for advanced or recurrent cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Camptothecin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Irinotecan; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Phase I-II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Granulocyte Colony-Stimulating Factor; Humans; Irinotecan; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Recombinant Proteins; Recurrence; Uterine Cervical Neoplasms | 2004 |
[A dose escalation study of concurrent chemoradiation therapy with nedaplatin for cervical cancer].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukopenia; Maximum Tolerated Dose; Middle Aged; Nausea; Organoplatinum Compounds; Uterine Cervical Neoplasms; Vomiting, Anticipatory | 2005 |
Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Injections, Intravenous; Middle Aged; Organoplatinum Compounds; Radiotherapy, Adjuvant; Survival Analysis; Uterine Cervical Neoplasms | 2006 |
Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Organoplatinum Compounds; Platinum; Radioisotope Teletherapy; Uterine Cervical Neoplasms | 2007 |
Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501).
Topics: Adenocarcinoma; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Humans; Organoplatinum Compounds; Radiotherapy, High-Energy; Uterine Cervical Neoplasms | 2007 |
A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Gamma Rays; Humans; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2008 |
Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intramuscular; Melanoma, Experimental; Mice; Mice, Inbred Strains; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Organoplatinum Compounds; Peplomycin; Prognosis; Skin Neoplasms; Uterine Cervical Neoplasms | 1993 |
[Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Ifosfamide; Middle Aged; Nausea; Organoplatinum Compounds; Pilot Projects; Uterine Cervical Neoplasms; Vomiting | 1997 |
A dose-finding study of nedaplatin and cyclophosphamide for patients with gynecological malignancies.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Erythrocyte Count; Feasibility Studies; Female; Humans; Infusions, Intravenous; Leukocyte Count; Middle Aged; Neutrophils; Organoplatinum Compounds; Ovarian Neoplasms; Platelet Count; Remission Induction; Survival Rate; Uterine Cervical Neoplasms | 1999 |
[Phase I study of a combination chemotherapy of nedaplatin and cisplatin].
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1999 |
Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Dose-Response Relationship, Drug; Embolization, Therapeutic; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Infusions, Intravenous; Magnetic Resonance Imaging; Middle Aged; Organoplatinum Compounds; Treatment Outcome; Uterine Cervical Neoplasms | 2001 |
[Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Diarrhea; Drug Administration Schedule; Female; Humans; Hysterectomy; Infusions, Intravenous; Middle Aged; Nausea; Neoadjuvant Therapy; Organoplatinum Compounds; Radiotherapy, Adjuvant; Uterine Cervical Neoplasms; Vomiting, Anticipatory | 2001 |
Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Organoplatinum Compounds; Survival Rate; Uterine Cervical Neoplasms; Uterine Neoplasms | 2001 |
[Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting | 1992 |
[Current status of CDDP analogs in gynecologic malignancies].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method; Doxorubicin; Drug Evaluation; Female; Genital Neoplasms, Female; Humans; Japan; Middle Aged; Multicenter Studies as Topic; Organoplatinum Compounds; Ovarian Neoplasms; Remission Induction; Uterine Cervical Neoplasms | 1989 |
44 other study(ies) available for nedaplatin and Cancer of Cervix
| Article | Year |
|---|---|
Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
Topics: Abdominal Pain; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Case-Control Studies; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Exanthema; Female; Humans; Hyperglycemia; Irinotecan; Nausea; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms; Vomiting | 2022 |
Propensity score matching analysis to comparing cisplatin versus nedaplatin based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Humans; Propensity Score; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2023 |
Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Consolidation Chemotherapy; Docetaxel; Female; Humans; Hysterectomy; Liposomes; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms | 2020 |
UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Glucuronosyltransferase; Humans; Hysterectomy; Irinotecan; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Pelvis; Polymorphism, Genetic; Prognosis; Progression-Free Survival; Retrospective Studies; Survival Analysis; Uterine Cervical Neoplasms | 2020 |
Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphatic Metastasis; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Sarcopenia; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2018 |
Comparison of Nedaplatin- and Cisplatin-Based Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer Patients: A Propensity Score Analysis.
Topics: Adult; Antineoplastic Agents; China; Cisplatin; Female; Humans; Middle Aged; Organoplatinum Compounds; Propensity Score; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
Recurrent cervical cancer in a patient who was compound heterozygous for UGT1A1*6 and UGT1A1*28 presenting with serious adverse events during irinotecan hydrochloride/nedaplatin therapy.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Glucuronosyltransferase; Heterozygote; Humans; Irinotecan; Neoplasm Recurrence, Local; Organoplatinum Compounds; Polymorphism, Genetic; Uterine Cervical Neoplasms | 2013 |
A novel diagnostic criterion for lymph node metastasis in cervical cancer using multi-detector computed tomography.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Female; Humans; Hysterectomy; Irinotecan; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Multidetector Computed Tomography; Neoadjuvant Therapy; Organoplatinum Compounds; Precision Medicine; Uterine Cervical Neoplasms | 2013 |
[Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Clinical efficacy of alternating chemoradiotherapy by conformal radiotherapy combined with intracavitary brachytherapy for high-risk cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Disease-Free Survival; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Organoplatinum Compounds; Radiotherapy Dosage; Radiotherapy, Conformal; Risk Assessment; Risk Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2014 |
Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
Topics: Adult; Aged; Antineoplastic Agents; Chemoradiotherapy; Disease-Free Survival; Female; Humans; Japan; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Prevalence; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2015 |
Nedaplatin salvage chemotherapy for cervical cancer.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Meta-Analysis as Topic; Organoplatinum Compounds; Prognosis; Salvage Therapy; Uterine Cervical Neoplasms | 2015 |
Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Retreatment; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2015 |
Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogr
Topics: Adult; Aged; Antineoplastic Agents; Chemoradiotherapy; Disease-Free Survival; Female; Humans; Hysterectomy; Kaplan-Meier Estimate; Middle Aged; Organoplatinum Compounds; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Uterine Cervical Neoplasms | 2015 |
Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Humans; Japan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Gamma Rays; Humans; Hysterectomy; Injections, Intravenous; Irinotecan; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Survival Analysis; Thrombocytopenia; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
Novel 1, 3-N, O-Spiroheterocyclic compounds inhibit heparanase activity and enhance nedaplatin-induced cytotoxicity in cervical cancer cells.
Topics: Antineoplastic Agents; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Female; Glucuronidase; HeLa Cells; Heterocyclic Compounds; Humans; Molecular Structure; Organoplatinum Compounds; Proto-Oncogene Proteins c-myc; Spiro Compounds; Telomerase; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2016 |
Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
Topics: Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors.
Topics: Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone.
Topics: Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer--irinotecan and platinum chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Humans; Hysterectomy; Irinotecan; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Postoperative whole pelvic radiotherapy plus concurrent chemotherapy versus extended-field irradiation for early-stage cervical cancer patients with multiple pelvic lymph node metastases.
Topics: Antineoplastic Agents; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Postoperative Care; Radiotherapy Dosage; Retrospective Studies; Uterine Cervical Neoplasms | 2011 |
Initial analysis of relationship between plasma platinum concentration and hematological adverse reaction associated with weekly chemotherapy using nedaplatin in combination with radiotherapy for cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Pilot Projects; Platinum; Thrombocytopenia; Uterine Cervical Neoplasms | 2010 |
The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2012 |
Predicting nedaplatin sensitivity of cervical cancer using the histoculture drug response assay.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Organoplatinum Compounds; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2011 |
[Dose escalation of domestic nedaplatin used in concurrent chemoradiotherapy for cervical cancer].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Radiotherapy, Conformal; Thrombocytopenia; Uterine Cervical Neoplasms; Vomiting | 2011 |
The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Female; Floxuridine; Fluorouracil; Humans; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Peplomycin; Thymidine Phosphorylase; Uterine Cervical Neoplasms | 2012 |
Fertility-sparing management for bulky cervical cancer using neoadjuvant transuterine arterial chemotherapy followed by vaginal trachelectomy.
Topics: Adult; Antineoplastic Agents; Camptothecin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Irinotecan; Lymph Node Excision; Neoadjuvant Therapy; Organoplatinum Compounds; Pregnancy; Retrospective Studies; Uterine Artery Embolization; Uterine Cervical Neoplasms; Vagina | 2012 |
Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiation therapy for early-stage cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Chemoradiotherapy; Female; Humans; Hysterectomy; Intestine, Large; Intestine, Small; Middle Aged; Organoplatinum Compounds; Organs at Risk; Peritoneal Cavity; Radiation Dosage; Radiography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; ROC Curve; Smoking; Uterine Cervical Neoplasms | 2013 |
Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Disease-Free Survival; Female; Humans; Irinotecan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Uterine Cervical Neoplasms | 2013 |
RAD52 variants predict platinum resistance and prognosis of cervical cancer.
Topics: Adult; Aged; Carboplatin; Drug Resistance, Neoplasm; Female; Genotype; Humans; Immunohistochemistry; Middle Aged; Models, Statistical; Organoplatinum Compounds; Polymorphism, Single Nucleotide; Rad52 DNA Repair and Recombination Protein; Uterine Cervical Neoplasms; Young Adult | 2012 |
Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes.
Topics: 3' Untranslated Regions; Apoptosis Regulatory Proteins; Case-Control Studies; Cell Line, Tumor; China; Cisplatin; Drug Resistance, Neoplasm; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; MicroRNAs; Organoplatinum Compounds; Paclitaxel; Polymorphism, Single Nucleotide; Risk; Uterine Cervical Neoplasms | 2013 |
Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Medical Records; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Pelvic Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Time Factors; Uterine Cervical Neoplasms; Young Adult | 2013 |
[Chemotherapy using nedaplatin for advanced gynecologic cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Adenosquamous; Combined Modality Therapy; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
[Outpatient chemotherapy in gynecologic oncology].
Topics: Ambulatory Care Facilities; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Humans; Irinotecan; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Uterine Cervical Neoplasms; Uterine Neoplasms | 2006 |
Radiation reduces carboplatin sensitivity and enhances nedaplatin sensitivity in cervical squamous cell carcinoma in vitro.
Topics: Carboplatin; Carcinoma, Squamous Cell; Cell Survival; Combined Modality Therapy; Drug Resistance, Neoplasm; Female; Humans; Organoplatinum Compounds; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2007 |
[Combined irinotecan (CPT-11) and nedaplatin (254-S) therapy for advanced and/or recurrent cervical cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Female; Humans; Irinotecan; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Recurrence; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Combination chemotherapy using intravenous nedaplatin (254-S) and intraarterial cisplatin (CDDP) with transcatheter arterial embolization (TAE) for a patient with uterine cervical cancer: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Organoplatinum Compounds; Remission Induction; Uterine Cervical Neoplasms | 1997 |
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.
Topics: Antineoplastic Agents; Carboplatin; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; In Vitro Techniques; Organoplatinum Compounds; Uterine Cervical Neoplasms | 1998 |
[Concurrent chemoradiotherapy for advanced cervical cancer--a pilot study].
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Female; Humans; Middle Aged; Organoplatinum Compounds; Pilot Projects; Radiation-Sensitizing Agents; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2001 |
Pharmacokinetic study of mitomycin C with emphasis on the influence of aging.
Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Uterine Cervical Neoplasms; Vindesine | 1992 |
[Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Peplomycin; Prognosis; Uterine Cervical Neoplasms | 1992 |
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].
Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Organoplatinum Compounds; Uterine Cervical Neoplasms | 1992 |
[Pharmacokinetics of cis-diammine (glycolato) platinum (254-S), a new platinum antitumor agent, following an intravenous and intraperitoneal infusion bioactive platinum concentration profile].
Topics: Aged; Antineoplastic Agents; Biological Assay; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Organoplatinum Compounds; Peritonitis; Platinum; Stomach Neoplasms; Uterine Cervical Neoplasms | 1990 |